Vitamin B17, also known as amygdalin, poses potential risks and lacks substantiated evidence for successfully combating cancer.
In a recent study published in Periodicum Biologorum, researchers examined the effect of Amygdalin on the treatment and recurrence of Endometriosis in an experimental rat study. However, it's important to clarify that the scientific consensus regarding Amygdalin, also known as Laetrile, is that it is not a safe or effective treatment for cancer.
This consensus is supported by multiple health authorities and clinical studies, which conclude that Laetrile has no proven anticancer effects and carries significant risks due to cyanide poisoning. Amygdalin, found in apricot seeds, can release cyanide in the body, which is poisonous. Unlike chemotherapy drugs designed to attack cancer cells, Laetrile can damage healthy cells and poses a danger rather than a benefit for cancer patients.
The Marion Institute provides information on the history and usage of Amygdalin and Laetrile, emphasizing their controversial status in the medical community. Cancer Research UK discusses Laetrile as a controversial cancer treatment, with no evidence supporting its efficacy. WebMD raises questions about the safety of Amygdalin as a cancer treatment, citing a lack of credible scientific evidence.
The National Cancer Institute's patient version on Laetrile/Amygdalin (PDQ®) does not recommend the use of Laetrile for the treatment of cancer due to a lack of evidence supporting its efficacy. The Cochrane Database of Systematic Reviews also does not support the use of Laetrile as a treatment for cancer based on the available evidence.
The European Food Safety Authority warns against the consumption of raw apricot kernels due to the risk of cyanide poisoning. The Research and Development Institute for Bovine Balotesti discusses natural plant toxins - cyanogenic glycosides in plant foods, including apricot kernels. The European Food Safety Authority Journal has also discussed the acute health risks related to the presence of cyanogenic glycosides in raw apricot kernels and products derived from raw apricot kernels.
It's crucial to note that while some studies have explored the anti-inflammatory effects of Prunus Armeniaca L. (Apricot) extracts, these findings do not translate to the safety or efficacy of Amygdalin or Laetrile as a cancer treatment.
In conclusion, it is strongly advised by experts to avoid amygdalin/Laetrile as a cancer treatment due to its potential toxicity and lack of proven benefits. Patients seeking cancer treatment are encouraged to consult with their healthcare providers and rely on evidence-based treatments.
References:
- Periodicum Biologorum
- The Marion Institute
- Research in Pharmaceutical Sciences
- Cancer Research UK
- National Cancer Institute's patient version on Laetrile/Amygdalin (PDQ®)
- The Research and Development Institute for Bovine Balotesti
- European Food Safety Authority Journal
- NIH PubChem
- Cochrane Database of Systematic Reviews
- WebMD
- European Food Safety Authority
- Science has shown that Laetrile, or Amygdalin, is not an effective treatment for cancer, due to its cyanide content which can lead to poisoning and pose risks to overall health and wellness.
- Nutrition and supplementary studies have highlighted the anti-inflammatory effects of Apricot extracts, but these findings do not support the use of Laetrile as a cancer treatment.
- Medical-conditions such as cancer require evidence-based treatments and careful consultation with healthcare providers, as controversial substances like Laetrile or Amygdalin have not been proven to be safe or effective.
